Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Equillium Inc (NQ: EQ ) 1.139 +0.009 (+0.81%) Streaming Delayed Price Updated: 9:30 AM EDT, Oct 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Equillium Inc < Previous 1 2 3 4 5 6 Next > Equillium Buys Inflammatory Bowel Disease Player In All-Stock Deal September 07, 2022 Via Benzinga EQ Stock Alert: Halper Sadeh LLP is Investigating Whether the Merger of Equillium, Inc. is Fair to Shareholders September 06, 2022 From Halper Sadeh LLP Via Business Wire Equillium to Acquire Metacrine in All-Stock Transaction September 06, 2022 From Equillium, Inc. Via Business Wire Equillium to Present at Two Upcoming Investor Conferences August 31, 2022 From Equillium, Inc. Via Business Wire Equillium Reports Second Quarter 2022 Financial Results and Provides Clinical Development Updates August 15, 2022 From Equillium, Inc. Via Business Wire Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session August 08, 2022 Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6... Via Benzinga Equillium Announces Presentation at the 3rd Annual Cytokine-Based Drug Development Summit July 28, 2022 From Equillium, Inc. Via Business Wire 89 Biggest Movers From Friday June 21, 2022 Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 15, 2022 Via Benzinga Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock June 14, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Friday May 27, 2022 During Friday's session, 59 stocks hit new 52-week lows. Via Benzinga Equillium to Present at Two Upcoming Investor Conferences May 17, 2022 From Equillium, Inc. Via Business Wire Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates May 12, 2022 From Equillium, Inc. Via Business Wire Equillium Announces Publication of Abstract for the Annual Congress of the European Hematology Association May 12, 2022 From Equillium, Inc. Via Business Wire Equillium Announces Three Poster Presentations at the Annual Meeting of The American Association of Immunologists May 09, 2022 From Equillium, Inc. Via Business Wire Equillium Announces Three Poster Presentations at the Transplantation & Cellular Meetings of the ASTCT and CIBMTR April 25, 2022 From Equillium, Inc. Via Business Wire Equillium Announces Oral Presentation at the Italian Society of Experimental Hematology April 04, 2022 From Equillium, Inc. Via Business Wire Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates March 23, 2022 From Equillium, Inc. Via Business Wire Equillium Announces Two Oral Presentations at the Annual Meeting of the European Society for Blood and Marrow Transplantation March 23, 2022 From Equillium, Inc. Via Business Wire Equillium's Itolizumab Shows Durable Clinical Response In GvHD Patients March 23, 2022 Equillium Inc (NASDAQ: EQ) announced two oral presentations on itolizumab at the Annual Meeting of the European Society for Blood and Marrow Transplantation. Via Benzinga Stocks That Hit 52-Week Lows On Thursday March 17, 2022 Thursday saw 34 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: SecureWorks (NASDAQ:SCWX) was the largest company by market cap to... Via Benzinga Equillium Adds Three Drugs To Its Pipeline Via Bioniz Acquisition February 16, 2022 Equillium Inc (NASDAQ: EQ), with only one asset in its pipeline, is expanding its drug development efforts via the acquisition of Bioniz Therapeutics. The deal,... Via Benzinga Equillium Acquires Bioniz Therapeutics Significantly Expanding Pipeline of Novel Immunomodulatory Drug Candidates February 16, 2022 From Equillium, Inc. Via Business Wire Equillium Provides Timing Update on Conference Presentations February 15, 2022 From Equillium, Inc. Via Business Wire Equillium to Present at the SVB Leerink Virtual Global Healthcare Conference February 09, 2022 From Equillium, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's After-Market Session January 21, 2022 Gainers Mustang Bio (NASDAQ:MBIO) shares ... Via Benzinga Equillium Announces Multiple Abstracts Accepted for Presentation at the Transplantation & Cellular Meetings of ASTCT and CIBMTR January 10, 2022 From Equillium, Inc. Via Business Wire Equillium to Present at the H.C. Wainwright Virtual BioConnect Conference January 05, 2022 From Equillium, Inc. Via Business Wire 10 Biggest Price Target Changes For Wednesday January 05, 2022 UBS cut the price target for Adobe Inc. (NASDAQ: ADBE) from $635 to $575. Adobe shares fell 2.3% to $541.06 in pre-market trading. SVB Leerink lowered the price target on... Via Benzinga 45 Biggest Movers From Yesterday January 05, 2022 Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.